WallStreetZenWallStreetZen

NASDAQ: PGNY
Progyny Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PGNY

Based on 10 analysts offering 12 month price targets for Progyny Inc

Min Forecast
$27.00-0.48%
Avg Forecast
$33.50+23.48%
Max Forecast
$40.00+47.44%

Should I buy or sell PGNY stock?

Based on 10 analysts offering ratings for Progyny Inc.

Strong Buy
Strong Buy
7 analysts 70%
Buy
1 analysts 10%
Hold
2 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their PGNY stock forecasts and price targets.

PGNY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-08
lockedlocked$00.00+00.00%2026-08-21
lockedlocked$00.00+00.00%2026-08-20
lockedlocked$00.00+00.00%2026-08-13
lockedlocked$00.00+00.00%2026-08-12
BTIG
Top 21%
80
Strong BuyMaintains$40.00+47.44%2026-07-24Find out why
Canaccord Genuity
Bottom 3%
3
Strong BuyMaintains$36.00+32.69%2026-07-21
KeyBanc
Bottom 2%
2
Strong BuyMaintains$35.00+29.01%2026-07-13
Bank of America
Top 12%
89
Strong BuyMaintains$31.00+14.26%2026-06-02Find out why
Barclays
Bottom 12%
12
Strong BuyMaintains$27.00-0.48%2026-05-18

1 of 1

Forecast return on equity

Is PGNY forecast to generate an efficient return?

Company
43.34%
Industry
22.66%
Market
168.71%
PGNY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PGNY forecast to generate an efficient return on assets?

Company
27.44%
Industry
16.87%
PGNY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PGNY earnings per share forecast

What is PGNY's earnings per share in the next 3 years based on estimates from 14 analysts?

Avg 1 year Forecast
$1.41+46.74%
Avg 2 year Forecast
$1.66+73.07%
Avg 3 year Forecast
$2.02+110.8%
PGNY's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

PGNY revenue forecast

What is PGNY's revenue in the next 3 years based on estimates from 14 analysts?

Avg 1 year Forecast
$1.4B+6.88%
Avg 2 year Forecast
$1.5B+17.79%
Avg 3 year Forecast
$1.6B+25.8%
PGNY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PGNY earnings growth forecast

How is PGNY forecast to perform vs Health Information Services companies and vs the US market?

Company
27.71%
Industry
18.11%
Market
31.22%
PGNY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PGNY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PGNY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PGNY revenue growth forecast

How is PGNY forecast to perform vs Health Information Services companies and vs the US market?

Company
8.12%
Industry
7.01%
Market
13.78%
PGNY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PGNY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PGNY vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
PGNY$27.13$33.50+23.48%Strong Buy
SDGR$29.02$18.67-35.68%Buy
PRVA$19.85$28.00+41.06%Buy
OMCL$32.23$53.33+65.48%Strong Buy
NUTX$208.79$308.33+47.68%Strong Buy
View Top Health Information Service Stocks

Progyny Stock Forecast FAQ

Is Progyny Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: PGNY) stock is to Strong Buy PGNY stock.

Out of 10 analysts, 7 (70%) are recommending PGNY as a Strong Buy, 1 (10%) are recommending PGNY as a Buy, 2 (20%) are recommending PGNY as a Hold, 0 (0%) are recommending PGNY as a Sell, and 0 (0%) are recommending PGNY as a Strong Sell.

If you're new to stock investing, here's how to buy Progyny stock.

What is PGNY's earnings growth forecast for 2026-2028?

(NASDAQ: PGNY) Progyny's forecast annual earnings growth rate of 27.71% is forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 18.11%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.22%.

Progyny's earnings in 2026 is $78,633,000.On average, 14 Wall Street analysts forecast PGNY's earnings for 2026 to be $108,085,040, with the lowest PGNY earnings forecast at $92,486,482, and the highest PGNY earnings forecast at $169,182,590. On average, 14 Wall Street analysts forecast PGNY's earnings for 2027 to be $127,481,575, with the lowest PGNY earnings forecast at $103,013,399, and the highest PGNY earnings forecast at $190,934,637.

In 2028, PGNY is forecast to generate $155,272,021 in earnings, with the lowest earnings forecast at $121,811,465 and the highest earnings forecast at $203,824,739.

What is PGNY's revenue growth forecast for 2026-2028?

(NASDAQ: PGNY) Progyny's forecast annual revenue growth rate of 8.12% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 7.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.

Progyny's revenue in 2026 is $1,310,764,000.On average, 14 Wall Street analysts forecast PGNY's revenue for 2026 to be $107,494,243,998, with the lowest PGNY revenue forecast at $102,276,821,734, and the highest PGNY revenue forecast at $111,714,217,888. On average, 14 Wall Street analysts forecast PGNY's revenue for 2027 to be $118,466,176,112, with the lowest PGNY revenue forecast at $110,563,315,918, and the highest PGNY revenue forecast at $126,599,216,700.

In 2028, PGNY is forecast to generate $126,522,489,902 in revenue, with the lowest revenue forecast at $117,468,727,738 and the highest revenue forecast at $134,195,169,702.

What is PGNY's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: PGNY) forecast ROA is 27.44%, which is higher than the forecast US Health Information Services industry average of 16.87%.

What is PGNY's Price Target?

According to 10 Wall Street analysts that have issued a 1 year PGNY price target, the average PGNY price target is $33.50, with the highest PGNY stock price forecast at $40.00 and the lowest PGNY stock price forecast at $27.00.

On average, Wall Street analysts predict that Progyny's share price could reach $33.50 by Sep 8, 2027. The average Progyny stock price prediction forecasts a potential upside of 23.48% from the current PGNY share price of $27.13.

What is PGNY's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: PGNY) Progyny's current Earnings Per Share (EPS) is $0.96. On average, analysts forecast that PGNY's EPS will be $1.41 for 2026, with the lowest EPS forecast at $1.21, and the highest EPS forecast at $2.21. On average, analysts forecast that PGNY's EPS will be $1.66 for 2027, with the lowest EPS forecast at $1.34, and the highest EPS forecast at $2.49. In 2028, PGNY's EPS is forecast to hit $2.02 (min: $1.59, max: $2.66).

What is PGNY's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: PGNY) forecast ROE is 43.34%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.